M2D2 Announces the first IMPACT Accelerator Program Cohort

10 startups have been selected to participate in the first cohort of the IMPACT Accelerator Program.

This week, M2D2 announced the finalists for its IMPACT Accelerator Program, a recently launched 12-week program designed to help early-stage companies advance their innovation. These 10 finalists will work closely with M2D2 and its network of experts, receiving 1-on-1 mentorship, education workshops, and access to lab equipment. After the 12-week program, the startups will be part of a public pitch event, where other life sciences startups and investors can learn more about their innovation. 

Continue reading

Stephen Tyrpak, Director of Clinical & Regulatory Affairs at Garwood Medical Devices, to Participate in Clinical Trial Program Sponsored by Johnson & Johnson Innovation – JLABS

Tyrpak will be a featured speaker and panelist as part of the UMass M2D2 Key Considerations & Best Practices” session on June 15.

BUFFALO, N.Y., June 11, 2021Stephen Tyrpak, director of clinical & regulatory affairs at Garwood Medical Devices, LLC, will be a featured speaker and panelist at a June 15 virtual event being coordinated by the Massachusetts Medical Device Center (M2D2) at UMass Lowell and sponsored by Johnson & Johnson Innovation – JLABS.

Tyrpak will share his expertise and insights regarding key considerations and best practices related to regulatory strategy in and out of the U.S., the importance of reimbursement considerations early on, and clinical study design and management for early-stage companies seeking regulatory approval. He is one of five participants in the third and final program in the M2D2 Clinical Trial Series.

Continue reading

Meet International MedTech Forum Presenter: Nesa Medtech

Nesa Medtech will present at the 2020 International MedTech Forum

As we count down the days to our first International MedTech Forum, we’d like you to meet another Indian Finalist, Nesa MedTech, who will be pitching their idea on Thursday, October 8.

Nesa Medtech is transforming women’s health by developing novel minimally invasive, safe, effective, and uterus-preserving technology to treat uterine fibroids. We talked with their Founder & CEO, Sreekar Kothamachu to learn about their journey.

Continue reading